CollPlant Biotechnologies (CLGN) Price to FCF (2018 - 2025)

CollPlant Biotechnologies (CLGN) has reported Price to FCF for 8 consecutive years, with 0.61 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Price to FCF rose 49.31% year-over-year to 0.61; the trailing twelve-month figure through Dec 2025 stood at 0.15 (up 49.17% YoY), and the FY2025 full-year result was 0.19, up 37.0% from the prior year.
• Price to FCF advanced to 0.61 in Q4 2025 per CLGN's latest filing, from 1.07 in the prior quarter.
• Across five years, Price to FCF topped out at 0.89 in Q3 2023 and bottomed at 17.77 in Q4 2021.
• Historically, Price to FCF has averaged 2.8 across 5 years, with a median of 1.93 in 2024.
• The widest YoY moves for Price to FCF: up 139.9% in 2021, down 850.78% in 2021.
• Over 5 years, Price to FCF stood at 17.77 in 2021, then soared by 95.77% to 0.75 in 2022, then tumbled by 360.02% to 3.46 in 2023, then surged by 64.98% to 1.21 in 2024, then jumped by 49.31% to 0.61 in 2025.
• According to Business Quant data, Price to FCF over the past three periods registered 0.61, 1.07, and 0.64 for Q4 2025, Q3 2025, and Q2 2025 respectively.